ARCHIVES

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

In Brief: NCI to Extend Frederick contract To SAIC; Klausner, Gallin, Gail Elected to IOM

October 24, 1996

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

July 31, 1998

Funds Earmarked From NCI Budget for Action Plan

October 24, 1996

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000